Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
1.550
-0.010 (-0.64%)
Apr 25, 2025, 11:27 AM EDT - Market open

Biodexa Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
42741324
Upgrade
Market Cap Growth
-66.49%-66.49%64.68%-67.88%-43.67%46.08%
Upgrade
Enterprise Value
3-41-3923
Upgrade
Last Close Price
1.564.0567.007880.0042000.0074800.00
Upgrade
PS Ratio
--14.475.0616.9650.31
Upgrade
PB Ratio
0.100.231.181.120.942.57
Upgrade
P/TBV Ratio
1.190.703.171.120.942.57
Upgrade
EV/Sales Ratio
--2.20-10.9748.15
Upgrade
Debt / Equity Ratio
0.090.090.100.200.070.04
Upgrade
Asset Turnover
--0.050.080.050.02
Upgrade
Quick Ratio
0.470.471.202.276.063.02
Upgrade
Current Ratio
1.751.751.262.476.393.10
Upgrade
Return on Equity (ROE)
-88.14%-88.14%-180.59%-112.47%-63.60%-168.89%
Upgrade
Return on Assets (ROA)
-45.41%-45.41%-52.16%-60.55%-38.48%-32.76%
Upgrade
Return on Capital (ROIC)
-81.03%-81.03%-93.86%-74.41%-48.07%-40.89%
Upgrade
Earnings Yield
-179.47%-304.89%-128.44%-216.38%-55.71%-128.57%
Upgrade
FCF Yield
-409.20%-653.00%-124.32%-200.95%-64.56%-55.11%
Upgrade
Buyback Yield / Dilution
-1468.08%-1468.08%----
Upgrade
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q